{"id":"https://openalex.org/W7220836871","doi":"https://doi.org/10.3389/fphar.2026.1948258","title":"Biologic and small-molecule therapies for inflammatory bowel disease: mechanisms, comparative evidence and the emerging pipeline","display_name":"Biologic and small-molecule therapies for inflammatory bowel disease: mechanisms, comparative evidence and the emerging pipeline","publication_year":2026,"publication_date":"2026-10-07","ids":{"openalex":"https://openalex.org/W7220836871","doi":"https://doi.org/10.3389/fphar.2026.1948258","pmid":"https://pubmed.ncbi.nlm.nih.gov/42909122","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13683838"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1948258","doi":"https://doi.org/10.3389/fphar.2026.1948258","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1948258","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1948258/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1948258/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157807203","display_name":"Longliang Wu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405272074","display_name":"Beijing Medical Award Foundation","ror":"https://ror.org/03gzgaa54","country_code":"CN","type":"nonprofit","lineage":["https://openalex.org/I4405272074"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Longliang Wu","raw_affiliation_strings":["Professional Committee of High-Quality Multidisciplinary Team Care for Inflammatory Bowel Disease, Beijing Medical Award Foundation","Shanghai Longliang Yuanjian Medical Technology Co., Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Professional Committee of High-Quality Multidisciplinary Team Care for Inflammatory Bowel Disease, Beijing Medical Award Foundation","institution_ids":["https://openalex.org/I4405272074"]},{"raw_affiliation_string":"Shanghai Longliang Yuanjian Medical Technology Co., Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5157822549","display_name":"Cuiping Yang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I2801556517","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2801556517"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Cuiping Yang","raw_affiliation_strings":["Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2801556517"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070912425","display_name":"\u5434\u575a\u70af","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183067930","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04","country_code":"CN","type":"education","lineage":["https://openalex.org/I183067930"]},{"id":"https://openalex.org/I4210135742","display_name":"Shanghai First People's Hospital","ror":"https://ror.org/04a46mh28","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210135742"]},{"id":"https://openalex.org/I4405272074","display_name":"Beijing Medical Award Foundation","ror":"https://ror.org/03gzgaa54","country_code":"CN","type":"nonprofit","lineage":["https://openalex.org/I4405272074"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Jianjiong Wu","raw_affiliation_strings":["Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","Professional Committee of High-Quality Multidisciplinary Team Care for Inflammatory Bowel Disease, Beijing Medical Award Foundation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","institution_ids":["https://openalex.org/I183067930","https://openalex.org/I4210135742"]},{"raw_affiliation_string":"Professional Committee of High-Quality Multidisciplinary Team Care for Inflammatory Bowel Disease, Beijing Medical Award Foundation","institution_ids":["https://openalex.org/I4405272074"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5070912425","https://openalex.org/A5157822549"],"corresponding_institution_ids":["https://openalex.org/I183067930","https://openalex.org/I2801556517","https://openalex.org/I4210135742","https://openalex.org/I4405272074"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.56402439,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1948258","last_page":"1948258"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10134","display_name":"Inflammatory Bowel Disease","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2715","display_name":"Gastroenterology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/inflammatory-bowel-disease","display_name":"inflammatory bowel disease","score":1.0},{"id":"https://openalex.org/keywords/ulcerative-colitis","display_name":"ulcerative colitis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/crohn-s-disease","display_name":"Crohn's disease","score":1.0},{"id":"https://openalex.org/keywords/biological-therapy","display_name":"biologic therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/small-molecule-therapy","display_name":"small molecule therapy","score":0.984000027179718},{"id":"https://openalex.org/keywords/sphingosine-1-phosphate-receptor-modulator","display_name":"sphingosine-1-phosphate receptor modulator","score":0.9309999942779541},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.9629999995231628},{"id":"https://openalex.org/keywords/obefazimod","display_name":"obefazimod","score":0.7940000295639038},{"id":"https://openalex.org/keywords/acute-severe-ulcerative-colitis","display_name":"acute severe ulcerative colitis","score":0.7419999837875366},{"id":"https://openalex.org/keywords/endoscopic-remission","display_name":"endoscopic remission","score":0.7310000061988831},{"id":"https://openalex.org/keywords/treat-to-target","display_name":"treat-to-target","score":0.7609999775886536},{"id":"https://openalex.org/keywords/biomarkers","display_name":"biomarkers","score":0.7070000171661377},{"id":"https://openalex.org/keywords/regulatory-approval","display_name":"regulatory approval","score":0.49799999594688416},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.414000004529953}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8780999779701233},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.6269000172615051},{"id":"https://openalex.org/C2778260677","wikidata":"https://www.wikidata.org/wiki/Q917447","display_name":"Inflammatory bowel disease","level":3,"score":0.5583999752998352},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.529699981212616},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5095999836921692},{"id":"https://openalex.org/C2778886723","wikidata":"https://www.wikidata.org/wiki/Q3530324","display_name":"Tofacitinib","level":3,"score":0.4657000005245209},{"id":"https://openalex.org/C2776207728","wikidata":"https://www.wikidata.org/wiki/Q7918002","display_name":"Vedolizumab","level":4,"score":0.43939998745918274},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43639999628067017},{"id":"https://openalex.org/C2781069245","wikidata":"https://www.wikidata.org/wiki/Q12204","display_name":"Tuberculosis","level":2,"score":0.38019999861717224},{"id":"https://openalex.org/C2910824759","wikidata":"https://www.wikidata.org/wiki/Q6060674","display_name":"Investigational Drugs","level":3,"score":0.3614000082015991},{"id":"https://openalex.org/C2777589142","wikidata":"https://www.wikidata.org/wiki/Q6770899","display_name":"Marketing authorization","level":2,"score":0.3433000147342682},{"id":"https://openalex.org/C2781228260","wikidata":"https://www.wikidata.org/wiki/Q415411","display_name":"Anakinra","level":3,"score":0.34040001034736633},{"id":"https://openalex.org/C3018359032","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Safety profile","level":3,"score":0.3393999934196472},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3361999988555908},{"id":"https://openalex.org/C112392421","wikidata":"https://www.wikidata.org/wiki/Q903451","display_name":"Janus kinase","level":3,"score":0.3327000141143799},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.3077000081539154},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.29679998755455017},{"id":"https://openalex.org/C149892131","wikidata":"https://www.wikidata.org/wiki/Q14914156","display_name":"Interleukin 1 receptor antagonist","level":5,"score":0.2921000123023987},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2919999957084656},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.28999999165534973},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.287200003862381},{"id":"https://openalex.org/C2777138892","wikidata":"https://www.wikidata.org/wiki/Q415264","display_name":"Infliximab","level":3,"score":0.2694999873638153},{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.25540000200271606},{"id":"https://openalex.org/C2780132546","wikidata":"https://www.wikidata.org/wiki/Q348260","display_name":"Adalimumab","level":3,"score":0.2508000135421753}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1948258","doi":"https://doi.org/10.3389/fphar.2026.1948258","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1948258","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1948258/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13683838","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683838/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13683838/pdf/fphar-17-1948258.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:42909122","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42909122","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:805ddda32d9a446eafa8a20a47b0d59b","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/805ddda32d9a446eafa8a20a47b0d59b","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1948258","doi":"https://doi.org/10.3389/fphar.2026.1948258","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1948258","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1948258/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322999","display_name":"Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04"},{"id":"https://openalex.org/F4320330117","display_name":"Ruijin Hospital","ror":"https://ror.org/01hv94n30"},{"id":"https://openalex.org/F4320335305","display_name":"School of Medicine, Shanghai Jiao Tong University","ror":"https://ror.org/0220qvk04"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220836871.pdf","grobid_xml":"https://content.openalex.org/works/W7220836871.grobid-xml"},"referenced_works_count":127,"referenced_works":["https://openalex.org/W1234479506","https://openalex.org/W1488772574","https://openalex.org/W1622884606","https://openalex.org/W1961451051","https://openalex.org/W1979817634","https://openalex.org/W1987925515","https://openalex.org/W2003835888","https://openalex.org/W2013381560","https://openalex.org/W2014239382","https://openalex.org/W2017295150","https://openalex.org/W2025060311","https://openalex.org/W2035289421","https://openalex.org/W2053889157","https://openalex.org/W2056348171","https://openalex.org/W2064275071","https://openalex.org/W2064485014","https://openalex.org/W2077531651","https://openalex.org/W2079295802","https://openalex.org/W2092863985","https://openalex.org/W2104547589","https://openalex.org/W2106136830","https://openalex.org/W2111362292","https://openalex.org/W2112082141","https://openalex.org/W2126807394","https://openalex.org/W2143710323","https://openalex.org/W2143747121","https://openalex.org/W2161685971","https://openalex.org/W2162766966","https://openalex.org/W2162805528","https://openalex.org/W2171297959","https://openalex.org/W2182578492","https://openalex.org/W2287490075","https://openalex.org/W2290216613","https://openalex.org/W2462748655","https://openalex.org/W2478193138","https://openalex.org/W2561041192","https://openalex.org/W2604780989","https://openalex.org/W2611548364","https://openalex.org/W2613299853","https://openalex.org/W2744879509","https://openalex.org/W2745479750","https://openalex.org/W2762039216","https://openalex.org/W2766046358","https://openalex.org/W2781482422","https://openalex.org/W2794595980","https://openalex.org/W2802146664","https://openalex.org/W2809380200","https://openalex.org/W2917617858","https://openalex.org/W2919081348","https://openalex.org/W2922297668","https://openalex.org/W2949255324","https://openalex.org/W2970843227","https://openalex.org/W2971538989","https://openalex.org/W2976731348","https://openalex.org/W2978880955","https://openalex.org/W2979395900","https://openalex.org/W2990295318","https://openalex.org/W2994956663","https://openalex.org/W2995014054","https://openalex.org/W3000586022","https://openalex.org/W3004601288","https://openalex.org/W3008528924","https://openalex.org/W3010990895","https://openalex.org/W3085001985","https://openalex.org/W3092547488","https://openalex.org/W3097599655","https://openalex.org/W3108618281","https://openalex.org/W3112731988","https://openalex.org/W3115410759","https://openalex.org/W3144460252","https://openalex.org/W3157525851","https://openalex.org/W3157961148","https://openalex.org/W3164964548","https://openalex.org/W3166073592","https://openalex.org/W3195954854","https://openalex.org/W3202460246","https://openalex.org/W3212891161","https://openalex.org/W3213391978","https://openalex.org/W3213907938","https://openalex.org/W3214731670","https://openalex.org/W4200136929","https://openalex.org/W4205253993","https://openalex.org/W4210258765","https://openalex.org/W4210529991","https://openalex.org/W4221008642","https://openalex.org/W4233817719","https://openalex.org/W4281627373","https://openalex.org/W4281674067","https://openalex.org/W4281924689","https://openalex.org/W4281951137","https://openalex.org/W4291397332","https://openalex.org/W4296483181","https://openalex.org/W4304692114","https://openalex.org/W4307371604","https://openalex.org/W4318762665","https://openalex.org/W4321595792","https://openalex.org/W4322762554","https://openalex.org/W4361296348","https://openalex.org/W4377966457","https://openalex.org/W4382363169","https://openalex.org/W4383314702","https://openalex.org/W4384938926","https://openalex.org/W4386564493","https://openalex.org/W4389728639","https://openalex.org/W4391256216","https://openalex.org/W4392059660","https://openalex.org/W4398255413","https://openalex.org/W4400723326","https://openalex.org/W4400883057","https://openalex.org/W4401725450","https://openalex.org/W4402120101","https://openalex.org/W4402826911","https://openalex.org/W4403711303","https://openalex.org/W4404505314","https://openalex.org/W4404581096","https://openalex.org/W4405016506","https://openalex.org/W4405467033","https://openalex.org/W4407036622","https://openalex.org/W4408567665","https://openalex.org/W4410290285","https://openalex.org/W4410997958","https://openalex.org/W4411476038","https://openalex.org/W4412522538","https://openalex.org/W4412555545","https://openalex.org/W4414789343","https://openalex.org/W7133503675","https://openalex.org/W7137814807"],"related_works":["https://openalex.org/W4385759506","https://openalex.org/W4212828593","https://openalex.org/W4214731962","https://openalex.org/W3154911979","https://openalex.org/W4296028018","https://openalex.org/W4403438926","https://openalex.org/W7131293014","https://openalex.org/W2750824223","https://openalex.org/W2786821373","https://openalex.org/W7203608076"],"abstract_inverted_index":{"Inflammatory":[0],"bowel":[1],"disease":[2,10],"(IBD),":[3],"comprising":[4],"ulcerative":[5,230],"colitis":[6],"(UC)":[7],"and":[8,51,57,73,142,163,178,180,197,202,207,214,239,247,251],"Crohn's":[9],"(CD),":[11],"is":[12,235],"a":[13,58,104,130],"chronic":[14],"immune-mediated":[15],"disorder":[16],"of":[17,29,116,151,200,260],"rising":[18],"global":[19],"prevalence,":[20],"with":[21,80,94],"newly":[22,242],"industrialised":[23,243],"nations":[24],"now":[25],"entering":[26],"the":[27,74,99,114,138,143,189,258],"phase":[28],"most":[30],"rapid":[31],"growth.":[32],"Its":[33],"therapeutic":[34],"landscape":[35],"has":[36],"transformed":[37],"since":[38],"2020.":[39],"Three":[40,119],"selective":[41],"interleukin":[42],"(IL)-23p19":[43],"antagonists":[44],"have":[45,64,70,88,122],"been":[46],"approved":[47,201],"for":[48,205],"both":[49],"UC":[50],"CD;":[52],"two":[53,223],"sphingosine-1-phosphate":[54],"receptor":[55,146],"modulators":[56],"second-generation":[59],"Janus":[60],"kinase":[61],"(JAK)":[62],"inhibitor":[63],"entered":[65],"routine":[66],"practice;":[67],"subcutaneous":[68],"formulations":[69],"altered":[71],"delivery;":[72],"first":[75],"formal":[76],"head-to-head":[77],"trials,":[78],"together":[79],"placebo-controlled":[81],"trials":[82],"incorporating":[83],"an":[84],"active":[85],"reference":[86],"arm,":[87],"begun":[89],"to":[90],"replace":[91],"indirect":[92],"comparison":[93],"direct":[95],"evidence.":[96],"In":[97],"parallel,":[98],"ORAL":[100],"Surveillance":[101],"trial":[102],"prompted":[103],"class-wide":[105],"boxed":[106],"warning":[107],"that":[108],"recalibrated,":[109],"but":[110],"did":[111],"not":[112,132,253],"eliminate,":[113],"role":[115],"JAK":[117],"inhibitors.":[118],"further":[120],"strategies":[121],"generated":[123],"late-phase":[124],"data:":[125],"anti-TL1A":[126],"antibodies,":[127],"which":[128],"target":[129],"pathway":[131],"previously":[133],"addressed":[134],"pharmacologically":[135],"in":[136,241],"IBD;":[137],"miR-124":[139],"enhancer":[140],"obefazimod;":[141],"oral":[144],"IL-23":[145],"antagonist":[147],"peptide":[148],"icotrokinra.":[149],"Several":[150],"these":[152],"results":[153],"are":[154,217],"available":[155],"only":[156],"from":[157],"conference":[158],"presentations":[159],"or":[160],"company":[161],"announcements":[162],"await":[164],"peer":[165],"review.":[166],"Despite":[167],"this":[168],"expansion,":[169],"induction":[170],"remission":[171,182],"rates":[172,183],"remain":[173],"clustered":[174],"between":[175],"roughly":[176],"15%":[177],"50%,":[179],"endoscopic":[181],"lower":[184],"still.":[185],"This":[186],"review":[187],"synthesises":[188],"mechanistic":[190],"basis,":[191],"pivotal":[192],"evidence,":[193],"comparative":[194],"effectiveness,":[195],"safety":[196],"regulatory":[198],"status":[199],"investigational":[203],"therapies":[204],"IBD,":[206],"how":[208],"treat-to-target":[209],"principles,":[210],"early":[211],"advanced":[212,233],"therapy":[213,234],"emerging":[215],"biomarkers":[216],"reshaping":[218],"positioning.":[219],"It":[220],"also":[221],"covers":[222],"areas":[224],"comparable":[225],"reviews":[226],"omit:":[227],"acute":[228],"severe":[229],"colitis,":[231],"where":[232,245],"least":[236],"well":[237],"evidenced,":[238],"positioning":[240],"nations,":[244],"tuberculosis":[246],"hepatitis":[248],"B":[249],"endemicity":[250],"reimbursement,":[252],"efficacy":[254],"alone,":[255],"often":[256],"determine":[257],"choice":[259],"mechanism.":[261]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-08T00:00:00"}